Singapore markets open in 4 hours 52 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
19.460-0.540 (-2.70%)
At close: 4:08PM HKT

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

45 Sha Mian North Street
Liwan District
Guangzhou 510130
86 20 6628 1217

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees25,168

Key executives

NameTitlePayExercisedYear born
Mr. Chuyuan LiExec. ChairmanN/AN/A1966
Mr. Hong LiGM & Exec. Director225.31kN/A1967
Ms. Ning ChengVice ChairmanN/AN/A1966
Mr. Jun YangVice ChairmanN/AN/A1970
Mr. Changhai WuDeputy GM & Exec. Director214.72kN/A1966
Ms. Juyan LiuExec. DirectorN/AN/A1964
Mr. Zhang ChunboDeputy GM & Exec. Director179.29kN/A1977
Mr. Haiwen HuangDeputy Gen. Mang.N/AN/A1981
Ms. Haoshan ZhengDeputy GM & Director of Bus. Admin. DepartmentN/AN/A1976
Mr. Jianxiong ZhengDeputy Gen. Mang.N/AN/A1970
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.


Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People's Republic of China and internationally. It operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. The company is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, ganoderma spore oil capsules, lozenges, tortoise herb jelly, etc. In addition, it invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2020, the company had 141 retail chain pharmacy outlets, which included 27 Cai Zhi Lin pharmacy outlets, 33 Jian Min pharmacy outlets, 36 GPC Prescription Pharmacy outlets, and 24 Hainan Guangyao Chenfei Pharmaceutical Chain outlets, as well as 21 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Corporate governance

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s ISS governance QualityScore as of 26 September 2021 is 3. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 5; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.